Distribution of S(-)-zacopride-insensitive [125I]R (+)-zacopride binding sites in the rat brain and peripheral tissues

European Journal of Pharmacology

Volumn 332, Issue 3, 1997, Pages 307-312

  Ge, Jian ^a   Barnes, Janine M ^a   Towers, Patrick ^b   Barnes, Nicholas M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b GENERAL ELECTRIC COMPANY   (United States)

Author keywords

125I R(+) Zacopride; Autoradiography; Brain rat; Peripheral tissue rat; R(+) site; Radioligand binding

Indexed keywords

GRANISETRON; MIANSERIN; PRAZOSIN; SEROTONIN; SULPIRIDE; ZACOPRIDE;

ADRENAL GLAND; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS CALLOSUM; DRUG RECEPTOR BINDING; ENANTIOMER; FRONTAL CORTEX; GLOBUS PALLIDUS; KIDNEY CORTEX; LIVER; MALE; MEDIAN RAPHE NUCLEUS; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PRIORITY JOURNAL; RAT; SEPTUM NUCLEUS; SPINAL CORD; SUBSTANTIA NIGRA; THALAMUS; TISSUE SPECIFICITY; VENTRAL TEGMENTUM;

ANIMALS; AUTORADIOGRAPHY; BENZAMIDES; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; BRAIN; IODINE RADIOISOTOPES; MALE; MIANSERIN; PRAZOSIN; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN; SEROTONIN ANTAGONISTS; STEREOISOMERISM; SULPIRIDE; TISSUE DISTRIBUTION;

EID: 0030874721     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01091-1     Document Type: Article

References (17)

1. Andrews P.L.R., Rapeport W.G., Sanger G.J. Neuropharmacology of emesis induced by anticancer drugs. Trends. Pharmacol. Sci. 9:1988;334-341.
2. 3 receptor antagonists. Pharmacol. Biochem. Behav. 37:1990;717-727.
3. Barnes J.M., Costall B., Ge J., Kelly M.E., Naylor R.J. The interaction of R(+) zacopride with PCPA to modify rodent aversive behaviour. Eur. J. Pharmacol. 218:1992;15-25.
4. Barnes J.M., Cneng C.H.K., Costall B., Ge J., Kelly M.E., Naylor R.J. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model. Eur. J. Pharmacol. 218:1992;91-100.
5. 3 receptor ligands. Neurosci. Biobehav. Rev. 16:1992;107-113.
6. Barnes N.M., Cheng C.H.K., Costall B., Ge J., Naylor R.J. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by R(+)- and S(-) zacopride. Br. J. Pharmacol. 107:1992;233-239.
7. 4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn-Schmiedeberg's Arch. Pharmacol. 343:1991;439-446.
8. 3 antagonists in neuropsychiatric disorders. CNS Drugs. 3:1995;363-392.
9. Cheng C.H.K., Costall B., Ge J., Naylor R.J. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats. Br. J. Pharmacol. 110:1993;1079-1084.
10. 3 receptors. Pharmacol. Ther. 47:1990;181-202.
11. Flippin L.A., Carter D.S., berger J., Clark R.D., Bonhaus D.W., Leung E., Eglen R.M. (R)-3-(6-chloro-1-isopropylbenzimidazole-4-carboxamido)quinuclidine: A high affinity ligand for the (R)-zacopride binding site. Bioorg. Med. Chem. Lett. 6:1996;477-480.
12. 3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system. Eur. J. Pharmacol. 211:1992;133-136.
13. 3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues. Eur. J. Pharmacol. 247:1993;45-56.
14. 3 binding sites in rat brain cortical membranes Biochem. Pharmacol. 38:1989;1693-1702.
15. Sancilio L.F., Pinkus L.M., Jackson C.B., Munson H.R. Studies on the emetic and antiemetic properties of zacopride and its enantiomers. Eur. J. Pharmacol. 192:1991;365-368.
16. 3H ]-granisetron Br. J. Pharmacol. 116:1995;1781-1786.
17. Young R., Johnson D.J. Anxiolytic-like activity of R(+) and S(-)-zacopride in mice. Eur. J. Pharmacol. 201:1991;151-155.